Page last updated: 2024-08-24

imiquimod and HIV Coinfection

imiquimod has been researched along with HIV Coinfection in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (5.26)18.2507
2000's20 (35.09)29.6817
2010's28 (49.12)24.3611
2020's6 (10.53)2.80

Authors

AuthorsStudies
Bhari, N; Gupta, S; Sindhuja, T1
Deng, L; Dickson, MA; Gu, L; Kurtansky, N; Lezcano, C; Lin, E; Liu, S; Markova, A; Neumann, NM; Noor, S; Pulitzer, M; Rossi, A; Stoll, J; Yang, N1
Bastida, C; Blanco, JL; Cranston, RD; Fuertes, I; Lopez-Cabezas, C; Mallolas, J; Ordi, J; Rodríguez-Carunchio, L1
Barroso Dos Reis, HL; Campos, LG; da Silva Campos, LC; Jacomele Caldas, JV; Miranda, AE; Pedras Almeida, SL; Salume Costa, FL; Tosato Boldrini, NA1
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U1
Cavassini, M; Hoschler, K; Manuel, O; Mombelli, M; Pascual, M1
Moore, S; Rady, P; Tyring, S1
Baldelli, F; Cavazzoni, E; Leo, CA; Santorelli, C1
Baker, JR; Brand, RM; Cranston, RD; Janocko, L; McGowan, I; Siegel, A1
Boesecke, C; Kalff, JC; Pantelis, D; Rockstroh, J; Schwarze-Zander, C; Stoffels, B; Vilz, TO; Websky, MWV; Wesselmann, PC1
Clotet, B; García-Cuyás, F; Ornelas, A; Piñol, M; Revollo, B; Sirera, G; Vela, S; Videla, S1
de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ1
Hugh, JM; Nijhawan, RI; Osei-Tutu, A1
Dosekun, O; Farrugia, P; Lewis, F; Sethi, G1
Bravo, AI; Castro-Perez, GA; Mazzuoccolo, LD; Sorin, I1
Browne, R; McKendry, A; Narayana, S1
Chong, WS; Lim, JH; Lim, KS1
González-González, JG; González-Saldivar, G; Rodarte-Shade, M; Rodríguez-Gutiérrez, R1
Chirachanakul, P; Jiamton, S; Leeyaphan, C; Omcharoen, V; Prasertworonun, N; Punyaratabandhu, P; Surawan, TM1
Curto-Barredo, L; Deza, G; Martin-Ezquerra, G; Pujol, RM; Villar García, J1
Acharya, S; Arumainayagam, JT; Dhesi, I; Kasparis, C; Lau, C1
Dunne, EF; Introcaso, C; Park, IU1
Delforge, M; DeWit, S; Feoli, F; Libois, A; Nkuize, M; Willems, N1
Sharma, DP; Singh, J; Sinha, S; Tandon, S1
Kaul, R; Yudin, MH1
Alessi, E; Arancio, L; Cusini, M; Gaiani, F; Ramoni, S1
Mahto, M; Nathan, M; O'Mahony, C1
Lee, PK; Wilkins, KB1
Biasin, M; Borelli, M; Clerici, M; Lo Caputo, S; Mazzotta, F; Naddeo, V; Piacentini, L; Pierotti, P; Shearer, GM; Trabattoni, D1
Bercovitch, L; Lee, KC; Risser, J1
Barton, SE; Bower, M; Dixon, G; Fox, PA; Francis, N; Nathan, M; Singh, N; Weir, J1
Agut, H; Caumes, E; Challine, D; Deback, C; Lascaux, AS; Lévy, Y; Melica, G1
Kaushal, S; Kopparthy, P; Merideth, M; Pulanic, TK; Stratton, P1
Hirokawa, D; Lee, SN; Samie, F; Woldow, A1
He, Q; Introcaso, CE; Kovarik, CL; Rady, PL; Tyring, SK1
Fox, PA1
Bourgault-Villada, I; Pavlovic, M; Roudier-Pujol, C; Saiag, P1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J1
Johnson, R; Stockfleth, E1
Alessi, E; Carminati, G; Cusini, M; Franchi, C; Locatelli, A; Salmaso, F; Vernaci, C; Zerboni, R1
Altmeyer, P; Brockmeyer, NH; Conant, MA; Hochdorfer, B; Kreuter, A; Stücker, M; Weiland, U1
Aubin, F; Drobacheff-Thiebaut, C; Laurent, R; Mougin, C; Pelletier, F; Venier, AG1
Costa, RR; de Freitas, VG; de Góis, NM; Kesselring, F; Kobata, MP; Ribalta, JC; Taha, NS1
Altmeyer, P; Brockmeyer, NH; Kreuter, A; Pfister, H; Wafaisade, A; Weissenborn, SJ; Wieland, U1
Bower, M; Dancey, G; Stebbing, J1
Rosen, T1
Altmeyer, P; Brockmeyer, NH; Hochdorfer, B; Kreuter, A; Pfister, H; Stücker, M; Swoboda, J; Weissenborn, SJ; Wieland, U1
Abbo, L; Dickinson, G; Doblecki, S; Haslett, PA; Shrestha, N; Vincek, V1
Correa, LA; Gaviria, A; Herrera, S; Sanclemente, G; Tyring, SK; Wolff, JC1
Altmeyer, P; Brockmeyer, NH; Gambichler, T; Kreuter, A; Pfister, H; Potthoff, A; Stücker, M; Swoboda, J; Wieland, U1
Cooper, DA; Couldwell, D; Cunningham, P; Goldstein, D; Hertzog, P; McCarville, S; Newell, M; Owens, M; Parrish, S; Tomkinson, E1
Conant, MA; Friedman-Kien, AE; Gilson, RJ; Nayagam, AT; Owens, ML; Pietig, DC; Shupack, JL; Smith, MH; Swann, RV; Weber, JN1
Pehoushek, J; Smith, KJ1
Smart, T1
Allan, PS; Das, S; Wade, AA1

Reviews

9 review(s) available for imiquimod and HIV Coinfection

ArticleYear
Asian guidelines for condyloma acuminatum.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:7

    Topics: Adult; Antiviral Agents; Child; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines

2022
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
    International journal of colorectal disease, 2021, Volume: 36, Issue:2

    Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections

2021
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
    International journal of dermatology, 2022, Volume: 61, Issue:11

    Topics: Acitretin; Cidofovir; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Mycophenolic Acid; Papillomaviridae; Papillomavirus Infections; Vaccines

2022
Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-15, Volume: 61 Suppl 8

    Topics: Adolescent; Aminoquinolines; Antiviral Agents; Anus Neoplasms; Centers for Disease Control and Prevention, U.S.; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines; Practice Guidelines as Topic; Prevalence; United States; Young Adult

2015
More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia.
    International journal of STD & AIDS, 2010, Volume: 21, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Vulvar Neoplasms

2010
Condyloma and other infections including human immunodeficiency virus.
    The Surgical clinics of North America, 2010, Volume: 90, Issue:1

    Topics: Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Anus Neoplasms; Chancroid; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Imiquimod; Male; Penicillin G; Proctitis; Rectal Diseases; Sexually Transmitted Diseases; Syphilis; Ulcer

2010
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
    Sexual health, 2012, Volume: 9, Issue:6

    Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cidofovir; Comorbidity; Cytosine; Female; Fluorouracil; Global Health; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Incidence; Male; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Trichloroacetic Acid

2012
[Cutaneous neoplasms].
    Praxis, 2003, Sep-03, Volume: 92, Issue:36

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors

2003
Imiquimod 5% cream for the treatment of cutaneous lesions in immunocompromised patients.
    Acta dermato-venereologica. Supplementum, 2003, Issue:214

    Topics: Adjuvants, Immunologic; Aminoquinolines; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Organ Transplantation; Skin Diseases

2003

Trials

8 trial(s) available for imiquimod and HIV Coinfection

ArticleYear
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial.
    The Journal of infection, 2021, Volume: 83, Issue:3

    Topics: Antibodies, Viral; Hemagglutination Inhibition Tests; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Influenza Vaccines; Influenza, Human; Injections, Intramuscular; Seasons; Vaccines, Inactivated

2021
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Netherlands; Papillomaviridae; Prospective Studies

2013
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod.
    AIDS (London, England), 2010, Sep-24, Volume: 24, Issue:15

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carcinoma, Squamous Cell; Double-Blind Method; HIV Infections; HIV-1; Homosexuality, Male; Humans; Imiquimod; Male

2010
[Effects of imiquimod on latent human papillomavirus anal infection in HIV-infected patients].
    Annales de dermatologie et de venereologie, 2004, Volume: 131, Issue:11

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma; Double-Blind Method; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Prospective Studies; Risk Factors

2004
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
    Archives of dermatology, 2006, Volume: 142, Issue:11

    Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Suppositories; Treatment Outcome

2006
Effect of imiquimod in anogenital warts from HIV-positive men.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; Genital Diseases, Male; HIV Infections; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Secondary Prevention; Treatment Outcome

2007
Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:3

    Topics: Administration, Oral; Adult; Aminoquinolines; beta 2-Microglobulin; Female; HIV; HIV Infections; Humans; Imiquimod; Interferon Inducers; Interferons; Male; Middle Aged

1998
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
    AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; CD4 Lymphocyte Count; Condylomata Acuminata; Double-Blind Method; Drug Eruptions; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Safety

1999

Other Studies

40 other study(ies) available for imiquimod and HIV Coinfection

ArticleYear
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma.
    Journal of medical virology, 2023, Volume: 95, Issue:1

    Topics: Cryotherapy; Female; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Immunotherapy; Male; Middle Aged; Sarcoma, Kaposi; Sexual and Gender Minorities; Skin Neoplasms

2023
The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals.
    International journal of STD & AIDS, 2019, Volume: 30, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Rectal; Anal Canal; Anus Neoplasms; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Squamous Intraepithelial Lesions; Suppositories; Treatment Outcome; Warts

2019
Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 95

    Topics: Antiviral Agents; Coinfection; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Middle Aged; Ulcer; Vulva

2020
Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
    Sexually transmitted infections, 2017, Volume: 93, Issue:3

    Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Italy; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome

2017
A Pilot Study of the Immunologic, Virologic, and Pathologic Consequences of Intra-anal 5% Imiquimod in HIV-1-Infected Men With High-Grade Squamous Intraepithelial Lesions.
    Diseases of the colon and rectum, 2018, Volume: 61, Issue:3

    Topics: Adult; Aminoquinolines; Anal Canal; Anus Neoplasms; Carcinoma in Situ; Cytokines; HIV Infections; HIV-1; Humans; Imiquimod; Male; Papillomavirus Infections; Pilot Projects; Prospective Studies

2018
[Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod].
    Zentralblatt fur Chirurgie, 2019, Volume: 144, Issue:4

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; HIV; HIV Infections; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Retrospective Studies

2019
Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men.
    PloS one, 2018, Volume: 13, Issue:8

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Retroviral Agents; Anus Diseases; Condylomata Acuminata; Electrosurgery; Genotype; HIV Infections; Homosexuality, Male; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Infrared Rays; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult

2018
Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod.
    Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:3

    Topics: Acitretin; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Oral; Aminoquinolines; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Keratolytic Agents; Male; Middle Aged; Treatment Outcome

2013
Vulval disease in HIV-positive women attending a tertiary vulval dermatology clinic over a five-year period.
    International journal of STD & AIDS, 2013, Volume: 24, Issue:10

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Diseases

2013
Acquired epidermodysplasia verruciformis in a patient with congenital HIV infection.
    Actas dermo-sifiliograficas, 2013, Volume: 104, Issue:8

    Topics: Aminoquinolines; Antiretroviral Therapy, Highly Active; Biopsy; Cryosurgery; Electrocoagulation; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Keratinocytes; Male; Tretinoin; Young Adult

2013
Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    International journal of STD & AIDS, 2015, Volume: 26, Issue:6

    Topics: Acyclovir; Adult; Aminoquinolines; Antiviral Agents; Herpes Genitalis; Herpes Simplex; HIV Infections; HIV-1; HIV-2; Humans; Imiquimod; Male; Polymerase Chain Reaction; Simplexvirus; Treatment Outcome; Ulcer

2015
Dramatic clearance of HIV-associated bowenoid papulosis using combined oral acitretin and topical 5% imiquimod.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:8

    Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Bowen's Disease; Drug Therapy, Combination; HIV Infections; Humans; Imiquimod; Keratolytic Agents; Male; Skin Neoplasms

2014
Buschke-Lowenstein tumor.
    The American journal of the medical sciences, 2015, Volume: 349, Issue:1

    Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Buschke-Lowenstein Tumor; HIV Infections; Humans; Imiquimod; Male; Skin Neoplasms

2015
Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2015, Volume: 33

    Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ulcer

2015
Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
    The Journal of dermatology, 2015, Volume: 42, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged

2015
Acquired epidermodysplasia verruciformis in an HIV-positive patient.
    International journal of STD & AIDS, 2016, Volume: 27, Issue:11

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Epidermodysplasia Verruciformis; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin; Treatment Outcome

2016
Treatment of anal dysplasia in HIV-positive men who have sex with men in a large AIDS reference centre.
    Acta clinica Belgica, 2017, Volume: 72, Issue:1

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Feasibility Studies; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2017
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Dermatologic therapy, 2017, Volume: 30, Issue:3

    Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine

2017
Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.
    Infectious diseases in obstetrics and gynecology, 2008, Volume: 2008

    Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Resistance, Viral; Female; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Hypertrophy; Imiquimod; Treatment Outcome; Vulvar Diseases

2008
Penile intraepithelial carcinoma treated with imiquimod 1% in an HIV-positive patient.
    The Journal of dermatological treatment, 2009, Volume: 20, Issue:3

    Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Carcinoma in Situ; Cell Transformation, Neoplastic; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Penile Diseases; Penile Neoplasms; Risk Assessment; Time Factors; Treatment Outcome

2009
TLR activation pathways in HIV-1-exposed seronegative individuals.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Mar-01, Volume: 184, Issue:5

    Topics: Adaptive Immunity; Aminoquinolines; Cells, Cultured; Chemokine CCL3; Cytokines; Flow Cytometry; HIV Infections; HIV Seronegativity; HIV-1; Humans; Imiquimod; Immunity, Innate; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Poly I-C; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors; Tumor Necrosis Factor-alpha

2010
What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?
    Archives of dermatology, 2010, Volume: 146, Issue:8

    Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Antiretroviral Therapy, Highly Active; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Male; Treatment Outcome

2010
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
    Journal of medical virology, 2012, Volume: 84, Issue:2

    Topics: Acyclovir; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; HIV-1; Humans; Imiquimod; Lamivudine; Male; Middle Aged; Nelfinavir; Simplexvirus; Zidovudine

2012
Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.
    Obstetrics and gynecology, 2012, Volume: 119, Issue:2 Pt 2

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Neoplasms

2012
Treatment of recalcitrant herpes simplex virus with topical imiquimod.
    Cutis, 2011, Volume: 88, Issue:6

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Herpes Simplex; HIV Infections; Humans; Imiquimod; Male; Treatment Outcome

2011
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient.
    International journal of dermatology, 2012, Volume: 51, Issue:6

    Topics: Adult; Aminoquinolines; Amputation, Surgical; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA, Viral; Fingers; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Lip Neoplasms; Male; Mohs Surgery; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin Neoplasms

2012
Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy.
    AIDS (London, England), 2002, Jul-05, Volume: 16, Issue:10

    Topics: Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Diseases; Treatment Outcome

2002
5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy.
    International journal of STD & AIDS, 2004, Volume: 15, Issue:1

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Diseases; Case-Control Studies; Condylomata Acuminata; Drug Administration Schedule; Female; HIV Infections; Humans; Imiquimod; Male; Severity of Illness Index; Treatment Outcome

2004
Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream.
    Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:6

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; HIV Infections; Humans; Imiquimod; Male; Ointments

2004
Grade 3 vulvar and anal intraepithelial neoplasia in a HIV seropositive child--therapeutic result: case report.
    Clinical and experimental obstetrics & gynecology, 2005, Volume: 32, Issue:2

    Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Anus Neoplasms; Carcinoma; Child; Combined Modality Therapy; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Imiquimod; Immunocompromised Host; Low-Level Light Therapy; Papillomavirus Infections; Risk Assessment; Treatment Outcome; Vulvar Neoplasms

2005
5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata.
    Archives of dermatology, 2006, Volume: 142, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; DNA, Viral; Dose-Response Relationship, Drug; Electrocoagulation; Follow-Up Studies; HIV Infections; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Male; Rectal Diseases; Suppositories; Treatment Outcome; Viral Load

2006
A tale of three Hs: HPV, HIV & HAART.
    Future oncology (London, England), 2006, Volume: 2, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Female; HIV Infections; Humans; Imiquimod; Male; Mass Screening; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Viral Vaccines

2006
Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
    International journal of dermatology, 2006, Volume: 45, Issue:7

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; HIV Infections; Humans; Imiquimod; Male; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome

2006
Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-01, Volume: 44, Issue:3

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiviral Agents; Dendritic Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Imiquimod; Interferon Inducers; Male

2007
Immune boosters. Italian study finds immune booster useful against genital warts.
    TreatmentUpdate, 2004, Volume: 16, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; CD4 Lymphocyte Count; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Italy; Male; Viral Load

2004
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.
    The Journal of investigative dermatology, 2008, Volume: 128, Issue:8

    Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; Follow-Up Studies; HIV Infections; Human papillomavirus 16; Human papillomavirus 18; Humans; Imiquimod; Longitudinal Studies; Male; Papillomaviridae; Prospective Studies; Treatment Outcome

2008
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
    Archives of dermatology, 2001, Volume: 137, Issue:1

    Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; HIV Infections; HIV-1; Humans; Imiquimod; Male; Middle Aged

2001
International Congress on Chemotherapy.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9

    Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Aminoquinolines; Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Condylomata Acuminata; Cryptosporidiosis; Drug Carriers; Exonucleases; Foscarnet; HIV Infections; HIV Protease Inhibitors; Humans; Imiquimod; Liposomes; Roxithromycin

1995
Immune booster used to fight drug-resistant herpes.
    TreatmentUpdate, 2001, Volume: 13, Issue:4

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Microbial; Herpes Genitalis; HIV Infections; Humans; Imiquimod; Male

2001
Imiquimod and HIV transmission.
    International journal of STD & AIDS, 2002, Volume: 13, Issue:1

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Disease Transmission, Infectious; HIV Infections; HIV-1; Humans; Imiquimod; Warts

2002